The Future of theLower Respiratory Tract Therapeutics Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Lung Cancer Diagnostic And Screening Market?
The surge in lung cancer cases is projected to fuel the expansion of the lung cancer diagnostic and screening market. Characterized by uncontrolled growth of atypical cells in the lung tissues, lung cancer is a malicious disease that manifests symptoms such as persistent coughing, chest discomfort, and breathing difficulties. The diagnosis and screening for lung cancer enable patients to detect the illness early through various tests like incisional biopsy and bronchoscopy. Take for instance, in January 2023, the American Cancer Society, a US government organization, recorded roughly 238,340 new lung cancer cases (117,550 in men and 120,790 in women) in the United States. Moreover, an estimated 127,070 lung cancer related deaths were reported (comprising of 67,160 men and 59,910 women). Consequently, the escalating lung cancer incidence rate is stimulating the growth of the lung cancer diagnostic and screening market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12043&type=smp
#What is the Growth Potential of the Lung Cancer Diagnostic And Screening Market, and How Will It Perform by 2034?
The market size for lung cancer diagnosis and screening has seen considerable growth in the recent years. The projections indicate that it will surge from $2.34 billion in 2024 to $2.56 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%. The unprecedented growth witnessed in the past years can be credited to factors such as advancements in digital imaging, standardization of screening procedures, anti-tobacco public health campaigns, the foundation of cancer registries, and progress in the field of pathology analysis.
The market size for lung cancer diagnostic and screening is forecasted to experience substantial growth within the next few years, expanding to $3.69 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth across the forecast period is credited to the rising cases of lung cancer, increasing focus on early detection, more high-risk screening programs, the shift towards personalized medicine, and government initiatives with funding. Major trends within the forecast period encompass the appearance of new screening methods, advancements in biomarker testing, artificial intelligence (AI) integration, increase in liquid biopsy usage, concentration on early stage detection, and expansion of low-dose CT screening programs.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12043
What Are the Most Significant Market Trends Transforming theLung Cancer Diagnostic And Screening Market?
Prominent firms in the lung cancer diagnostic and screening market are advancing technologies such as lung cancer tests to boost early detection, enhance diagnostic precision, and promote personalized treatment protocols for patients likely to develop the disease. Lung cancer tests are diagnostic processes aimed at identifying lung cancer using multiple techniques, like imaging, biomarker assessment, and cytology tests. For instance, in December 2023, US-based biotech firm Freenome introduced PROACT LUNG. This trial of PROACT LUNG suggests a potentially transformative step in the field of lung cancer screening, which may facilitate early detection and improved patient results, while tackling current screening deficiencies.
What Are the Top Market Players Propelling the Growth of theLung Cancer Diagnostic And Screening Industry?
Major companies operating in the lung cancer diagnostic and screening market include Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, OncimmuneHoldings Plc, Broncus Medical Inc., OncoCyte, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix,
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Lung Cancer Diagnostic And Screening Market Are Driving Growth and Industry Transformations?
The lung cancer diagnostic and screening market covered in this report is segmented –
1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Imaging Devices, Biopsy Devices, Bronchoscopy Systems
2) By Consumables And Accessories: Biopsy Needles, Reagents And Assays, Imaging Contrast Agents, Patient Preparation Equipment, Sample Collection Kits, Laboratory Supplies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12043&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Lung Cancer Diagnostic And Screening Market?# Market?
North America was the largest region in the lung cancer diagnostic and screening market in 2024. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Lung Cancer Diagnostic And Screening Maret 2025, By The Business Research Company:
Hematology Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Personal Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/personal-services-global-market-report
Toiletries Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/toiletries-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
